Skip to Main Content

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Results: 1214 (Showing 1 to 20)
Title PubMed Id Authors Journal Abbreviation Year Studies
Modeling oral cancer screening in the United States population. 34864525 Cramer JD, Grauer J Oral Oncol 2022 NLST
Long-term Outcomes After Lung Cancer Resection in Smokers: Analysis of the National Lung Screening Trial. 34591149 Sesti J, Decker J, Bell J, Nguyen A, Lackey A, Turner AL, Hilden P, Paul S World J Surg 2022 NLST
Physical Activity and Total Daily Energy Expenditure in Older US Adults: Constrained versus Additive Models. 34334719 Willis EA, Creasy SA, Saint-Maurice PF, Keadle SK, Pontzer H, Schoeller D, Troiano RP, Matthews CE Med Sci Sports Exerc 2022 IDATA
Estimation and inference of predictive discrimination for survival outcome risk prediction models. 35061146 Li R, Ning J, Feng Z Lifetime Data Anal 2022 PLCO
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. 34995129 Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM J Clin Oncol 2022 PLCO
Surgical Outcomes in the National Lung Screening Trial Compared to Contemporary Practice. 35007506 Savitch SL, Zheng R, Abdelsattar ZM, Barta JA, Okusanya OT, Evans NR, Grenda TR Ann Thorac Surg 2022 NLST
Incidence of Head and Neck Cancer With Lung Cancer Screening: Secondary Analysis of a Randomized Controlled Trial. 34984679 Jassal JS, Grauer JS, Cramer JD Laryngoscope 2022 NLST
Big-Hypergraph Factorization Neural Network for Survival Prediction From Whole Slide Image. 34982683 Di D, Zhang J, Lei F, Tian Q, Gao Y IEEE Trans Image Process 2022 NLST
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. 35113855 Yarmolinsky J, Díez-Obrero V, Richardson TG, Pigeyre M, Sjaarda J, Paré G, Walker VM, Vincent EE, Tan VY, Obón-Santacana M, Albanes D, Hampe J, Gsur A, Hampel H, Pai RK, Jenkins M, Gallinger S, Casey G, Zheng W, Amos CI, International Lung Cancer Co… PLoS Med 2022 PLCO
Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis. 35048991 Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, Tsilidis KK, Barroso I, Chen J, Frayling T, Bull CJ, Vincent EE, Cotterchio M, Gruber SB, Pai RK, Newcomb PA, Perez-Cornago A, van Duijnhoven FJB, Van Guelpen B, Vodicka … J Natl Cancer Inst 2022 PLCO
Detection and staging of chronic obstructive pulmonary disease using a computed tomography-based weakly supervised deep learning approach. 35201409 Sun J, Liao X, Yan Y, Zhang X, Sun J, Tan W, Liu B, Wu J, Guo Q, Gao S, Li Z, Wang K, Li Q Eur Radiol 2022 NLST
AI-Driven Model for Automatic Emphysema Detection in Low-Dose Computed Tomography Using Disease-Specific Augmentation. 35182291 Nagaraj Y, Wisselink HJ, Rook M, Cai J, Nagaraj SB, Sidorenkov G, Veldhuis R, Oudkerk M, Vliegenthart R, van Ooijen P J Digit Imaging 2022 NLST
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. 35351104 Gelfond JA, Hernandez B, Goros M, Ibrahim JG, Chen MH, Sun W, Leach RJ, Kattan MW, Thompson IM, Ankerst DP, Liss M BMC Urol 2022 PLCO
Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data. 35319912 Hammer MM, Hunsaker AR AJR Am J Roentgenol 2022 NLST
Developing an understanding of artificial intelligence lung nodule risk prediction using insights from the Brock model. 35238972 Chetan MR, Dowson N, Price NW, Ather S, Nicolson A, Gleeson FV Eur Radiol 2022 NLST
Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study using the PLCO Cancer Screening Trial Data. 35534235 In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, Epplein M Cancer Epidemiol Biomarkers Prev 2022 PLCO
A graph-transformer for whole slide image classification. 35594209 Zheng Y, Gindra RH, Green EJ, Burks EJ, Betke M, Beane JE, Kolachalama VB IEEE Trans Med Imaging 2022 NLST
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. 33398198 Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, Momozawa Y, Fujita M, Muir K, Lophatananon A, Wan P, Le Marchand L, Wilkens LR, Steve… Nat Genet 2021 PLCO
Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer. 33444688 Cheng Y, Meng Y, Li S, Cao D, Ben S, Qin C, Hua L, Cheng G Gene 2021 PLCO
Deep convolutional neural networks to predict cardiovascular risk from computed tomography. 33514711 Zeleznik R, Foldyna B, Eslami P, Weiss J, Alexander I, Taron J, Parmar C, Alvi RM, Banerji D, Uno M, Kikuchi Y, Karady J, Zhang L, Scholtz JE, Mayrhofer T, Lyass A, Mahoney TF, Massaro JM, Vasan RS, Douglas PS, Hoffmann U, Lu MT, Aerts HJWL Nat Commun 2021 NLST